Specialty Hub/Patient Assistance Providers News Roundup: February 2024

Amplity Health appointed Chris Baker to the position of Chief Executive Officer (CEO), effective immediately. Michael A. Griffith, Amplity founder and long-standing CEO, will transition to the role of Chairman of the Board of Directors as part of a deliberate succession plan. In this capacity, he will continue to support Baker and the leadership team, but with a primary focus on building the visibility and awareness of Amplity in the biopharmaceutical market. Amplity Health is a contract medical and commercial organization that employs over 1,000 highly credentialed colleagues in 41 countries.

Fortrea announced the opening of its expanded non-commercial specialty pharmacy, FortreaRx™, located in Lake Mary, Florida, which offers advanced patient access solutions across the United States, including ambient and cold-chain distribution capabilities and expertise. Licensed in all 50 states and U.S. territories, FortreaRx delivers flexible, scalable solutions that meet the specific needs of its customers while providing medications to patients who may otherwise not have access to them. Non-commercial specialty pharmacies, like FortreaRx, provide these solutions on behalf of their pharmaceutical manufacturer customers and are uniquely positioned to serve as a bridge between pharmaceutical manufacturers and patients who meet the manufacturer requirements for prescription assistance.

Lumanity, a global strategic services partner, is realigning its strategic consulting capabilities to help clients more effectively create and demonstrate the value of assets throughout the development and commercialization lifecycle. With the addition of Clarion’s rebranding, Lumanity is realigning its Commercial, Medical Affairs, and Clinical and Regulatory Strategy teams into a single global Strategy Consulting capability. Lumanity’s Strategy Consulting team helps clients identify and create value inflection points for their assets and organizations throughout the product lifecycle. These inflection points occur at critical investment and execution milestones that ultimately determine the success of a product in the marketplace. The creation of this new Strategy Consulting team best leverages Lumanity’s unique and diverse set of deeply experienced strategists, data luminaries, subject matter experts, and proven problem solvers.

Two Labs launched its Sunshine Transparency and Aggregate Spend service. This service offering is designed to help emerging pharmaceutical manufacturers streamline their aggregate spend activities, including reporting payments and transfers of value provided to healthcare professionals (HCPs) and healthcare organizations (HCOs). This service is an expansion of Two Labs’ established compliance support and is spearheaded by Andy Parks, Vice President of Compliance, and Brian Fittipaldi, Director of Operations, Aggregate Spend. With a combined over two decades of experience in the Transparency reporting space, Two Labs’ Sunshine Transparency and Aggregate Spend experts bring a robust level of knowledge and proficiency to managing clients’ legislative requirements, ensuring compliance, and fostering transparency across their operations.

Takeaway: AMI’s annual Specialty Hub Service Providers Report provides comprehensive business intelligence on more than 75 companies